Live
- PM Modi to attend Christmas celebrations hosted by Catholic Bishops' Conference of India tomorrow
- ‘Dhop’ from ‘Game Changer’ lights up musical platforms
- Allu Arjun requests fans to stop using abusive language
- Rohit Pathak: A rising star in Indian cinema with powerful villain roles
- Pooja’s ‘final day of shot for 2024’ makes waves
- Nayini Rajender Reddy Addresses Press Conference at Hanumakonda Congress Office
- ‘Game Changer’ pre-release event in Dallas is a blockbuster
- NDMC Vice Chairman hits out at AAP's registration drive; labels it 'election gimmick'
- No place for Stokes as Root returns to England’s squad for India ODIs and Champions Trophy
- Kuwait bestows its highest honour 'The Order of Mubarak Al Kabeer' to PM Modi
Cabinet okays Rs 9,589-cr FDI in Suven Pharma
The proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies
New Delhi: The government on Wednesday approved a foreign investment of up to Rs 9,589 crore in Hyderabad-based Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.
The approval is for acquisition of up to 76.1 per cent shares of Suven Pharmaceuticals by Berhyanda by way of transfer of shares from existing promoter shareholders and public shareholders through mandatory open offer, an official release said after the meeting of Cabinet Committee on Economic Affairs. The aggregate foreign investment may increase to up to 90.1 per cent in Suven, the release said.
The proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies. The release further said the approval has been granted after examination of the proposal by departments concerned, RBI and Sebi and is subject to the fulfilment of all rules and regulations as applicable in this regard. Total foreign direct investment (FDI) in the pharmaceutical sector has been Rs 43,713 crore during last five years (from 2018-19 to 2022-23). The sector has witnessed significant growth in FDI of 58 per cent in the last financial year.
